Tisagenlecleucel Elicits Durable Response in Adults With Relapsed/Refractory Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update
Blood 2024 Jan 09;[EPub Ahead of Print], M Dreyling, NH Fowler, M Dickinson, J Martínez-López, A Kolstad, J Butler, M Ghosh, L Popplewell, JC Chavez, E Bachy, K Kato, H Harigae, MJ Kersten, CB Andreadis, PA Riedell, PJ Ho, JA Perez-Simon, AI Chen, LJ Nastoupil, B von Tresckow, AJ Ferreri, T Teshima, PE Patten, JP McGuirk, AL Petzer, F Offner, A Viardot, PL Zinzani, R Malladi, I Paule, A Zia, R Awasthi, X Han, D Germano, DS O'Donovan, RJ Ramos, HJ Maier, A Masood, C Thieblemont, SJ SchusterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.